Hanae Armitage

Custom designing proteins — a breakthrough recognized by the latest Nobel Prize in chemistry — could yield treatments that stop the worst of COVID-19 before it begins.

Welcome to Stanford Medicine's Health Compass podcast, your go-to source for bringing the latest medical research to life through engaging and relatable stories that connect with your everyday health experiences. Join Maya Adam, MD, Director of Health Media Innovation and a Stanford Medicine faculty member, as she interviews leading experts on crucial health topics featured in Stanford Medicine

Around 1.5 billion people globally experience some level of hearing loss -- that's nearly 20% of the world's population. Losing the ability to hear can be devastating, and navigating the potential treatments isn't always straight forward.

New drug treats a rare heart disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.

The U.S. Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed with a rare cardiovascular disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.

The COVID-19 pandemic accelerated the transition from in-person care to virtual care, as office visits increasingly gave way to televisits and email exchanges. The transition, while helpful during lockdowns, means that physicians now juggle packed schedules with increased electronic documentation and overstuffed inboxes.

Stanford Medicine researchers are using artificial intelligence to help identify the underlying biology behind Type 2 diabetes.

When new or expectant mothers experience depression in the peripartum period, serious problems can manifest for those children down the line.

Diabetes has long been lumped into two categories—type 1, which often appears in childhood, or type 2, which is associated with obesity and typically develops later in life. But scientists have learned that not all patients with type 2 diabetes are the same, with some patients varying in body weight, age of onset and other characteristics.

A new artificial intelligence tool will help Stanford Health Care physicians inform patients of their test results, with the goal of reducing administrative tasks.